Correlation of Clinical Parameters with Intracranial Outcome in Non-Small Cell Lung Cancer Patients with Brain Metastases Treated with Pd-1/Pd-L1 Inhibitors as Monotherapy

Correlation of Clinical Parameters with Intracranial Outcome in Non-Small Cell Lung Cancer Patients with Brain Metastases Treated with Pd-1/Pd-L1 Inhibitors as Monotherapy

There is a paucity of biomarkers for the prediction of intracranial (IC) outcome in immune checkpoint inhibitor (ICI)-treated non-small cell lung cancer (NSCLC) patients (pts) with brain metastases (BM). We identified 280 NSCLC pts treated with ICIs at Karolinska University Hospital, Sweden, and Uni...

Full description

Bibliographic Details
Main Authors: Konstantinos Rounis, Marcus Skribek, Dimitrios Makrakis, Luigi De Petris, Sofia Agelaki, Simon Ekman, Georgios Tsakonas
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:Cancers
Subjects:
NSCLC
brain metastases
immunotherapy
intracranial outcome
Online Access:https://www.mdpi.com/2072-6694/13/7/1562

Internet

https://www.mdpi.com/2072-6694/13/7/1562

Similar Items